US Equine Healthcare Market Size Likely to Grow at a CAGR of 7.23% By 2034

Market Size and Growth

As per the US Equine Healthcare Market size analysis conducted by the CMI team, the US equine healthcare market is expected to record a CAGR of 7.23% from 2025 to 2034. In 2025, the market size was USD 926.81 Million. By 2034, the valuation is anticipated to reach USD 1733.75 Million.

Overview

As per the industry experts at CMI, the U.S. equine healthcare market is likely to witness a decent CAGR during the forecast period. This could be attributed to rising equestrian activities, emphasis on preventive care, and technological advancements such as regenerative medicine and telemedicine. The key dynamics include increased zoonotic and the other equine ailments, which do drive demand for vaccines, along with higher awareness and spending on wellness and diagnostics.

Key Trends & Drivers

• Technological Advancements to Determine Growth: Use of telemedicine, CT scans, and EHRs (electronic health records) is improving equine healthcare. Also, there is a strong focus on prevention of diseases, supported by the updated protocols pertaining to vaccination and growing understanding regarding ailments such as West Nile Virus and zoonotic diseases. There are also advancements witnessed with regard to regenerative treatments like protein solutions and stem cells.

• Upgradations in Equine Pharmaceuticals to Catalyze the Market: Development of innovative treatments and medications is improving the ability to manage several equine health issues in an effective manner. The recent breakthroughs pertaining to anti-inflammatory drugs and pain management are showing promising results, thereby resulting in better recovery times.

Report Scope

SWOT Analysis

• Strengths: The U.S. equine healthcare market is adopting the advanced technologies such as telemedicine, AI, and improved diagnostics, thereby enhancing precision and efficiency. Raised understanding of horse nutrition, health, and preventive care is generating demand for more advanced services and products. The visible shift toward proactive wellness programs inclusive of regular check-ups and supplements is a prime growth driver. Rising investments in R&D activities are resulting in the discovery of novel treatment options and therapies.

• Weaknesses: The price of advanced equine healthcare is a noticeable barrier for both – veterinary practices and horse owners. There might also be challenges linked with development as well as approval of the new therapies and drugs. With the rise in preference for EHRs, data privacy and security have become a concern.

• Opportunities: Tailoring the treatments on the basis of genetics does offer a noticeable growth area. Adoption and development of advanced diagnostic tools like standing CT scanners allow for more precise detection of diseases. Demand for both – herbal and conventional supplements is expanding as the owners are looking for ways to improve the overall health of their horses. Using remote monitoring can enhance the access to care.

• Threats: The probability of zoonotic diseases spreading to humans from horses is one of the growing concerns that could result in stringent regulations with increasing costs. Recession could also result in a reduction in discretionary spending on equine healthcare. Rising resistance of the parasites to existing treatments does pose a challenge for the effective control of parasites.

List of the prominent players in the US Equine Healthcare Market:

• Arthrex Inc.
• Boehringer Ingelheim International GmbH
• Zoetis Services LLC
• Dechra
• Ceva Sante Animale
• Heska Corporation
• Merck & Co. Inc.
• Esaote SPA
• IDEXX Laboratories, Inc.
• Covetrus
• Elanco
• Cargill
• Others

The US Equine Healthcare Market is segmented as follows:

By Product

• Pharmaceuticals
  • Parasiticides
  • Anti-infectives
  • Anti-inflammatory & Analgesics
• Vaccines
• Medicinal Feed Additives
• Orthobiologics
• Diagnostics
  • Diagnostic Test Kits
  • Diagnostics Equipment
• Software & Services
  • Practice Management Software
  • Imaging Software
  • Telehealth Software

By Indication

• Musculoskeletal Disorders
• Parasitic Infections
• Equine Herpes Virus
• Equine Viral Arteritis (EVA)
• Equine Influenza
• West Nile Virus
• Tetanus

By Activity

• Sports/Racing
• Recreation

By Distribution Channel

• Veterinary Hospitals & Clinics
• e-Commerce
• Equestrian Facilities